The Wasan Laboratory in the Faculty of Pharmaceutical Sciences at the University of British Columbia in partnership with iCo Therapeutics Inc. (Vancouver BC, Canada) have developed a novel oral formulation of Amphotericin B to treat systemic fungal and parasitic infections. Amphotericin B is a polyene macrolide antibiotic used in the treatment of blood-borne fungal infections such as candidiasis and aspergillosis and parasitic infections such as visceral leishmaniasis.
Wasan lab develops novel oral formula... - Lung Conditions C...
Wasan lab develops novel oral formulation to treat systemic fungal infections.
Written by
2greys
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Yep B4 You Say It B12 Again ... But This Time Scientists Unravel B12 / GA 101 Secrets
Yumi Al Have To ..... Please :O Vitamin Microbiology could combat cancer as professor martin warren...
Withdrawal of some inhalers !!! Seretide etc corticosteroids ones,
What a shock to read they are to be stopping some corticosteroids, due to them bringing about...
Fluid E cigs and chronic lung disease update !
Well being pretty Anti E Cigs a think am turing corner on risk V benefit.
As most will know is a...
New Antimicrobial Peptide May Be Able to Treat Even Drug-Resistant CF Lung Infections.
Researchers at the University of Pittsburgh Center for Vaccine Research (CVR) have developed an...
Prednisone & Other Devils
(...In my time in this group, I've noticed some folks have never researched the medicines they're...
Experiences of amphotericin?
Results 
Treatment options for bronchiectasis
Freeman
